Search Login Register

Emitefur Summary

22 relevant articles (3 outcomes, 2 trials/studies) found for this Bio-Agent

Description: structure given in first source

Also Known As: 3 (3-(6-benzoyloxy-3-cyano-2-pyridyloxycarbonyl)benzoyl)-1-ethoxymethyl-5-fluorouracil; BOF A2; BOF-A2; Benzoic acid, 3-((3-(ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl)carbonyl)-, 6-(benzoyloxy)-3-cyano-2-pyridinyl ester

Key Diseases for which Emitefur is Relevant

  1. Stomach Neoplasms (Stomach Cancer) : 1 outcome 1 study in 2 results
  2. Small Cell Carcinoma (Small Cell Lung Cancer) : 1 outcome 1 study in 1 result
  3. Colorectal Neoplasms (Colorectal Cancer) : 1 outcome in 2 results
  4. Neoplasms (Cancer) : 12 results
  5. Yoshida Sarcoma : 2 results
Show All >>

Drugs Related to Emitefur

  1. Fluorouracil (Carac)
  2. Uracil
  3. Tegafur
  4. Prodrugs
  5. Leucovorin (Folinic Acid)
  6. capecitabine (Xeloda)
  7. Emitefur
  8. 2,6-dihydroxy-3-cyanopyridine
  9. 1-ethoxymethyl-5-fluorouracil
  10. irinotecan (Camptosar)
Show All >>

Therapies Related to Emitefur

  1. Adjuvant Chemotherapy
  2. Heterologous Transplantation (Xenotransplantation)
  3. Combination Drug Therapy (Combination Chemotherapy)
  4. Drug Therapy (Chemotherapy)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.